// App-Quantinova.ai

TCT-39 : Clinical Outcomes in SURTAVI Based on Revascularization Stratification

Researchers

Presenter

  • Lars Søndergaard

Principal Investigators

  • Jeffrey J. Popma

  • Michael J. Reardon

  • Thomas Engstroem

  • Nicolas Van Mieghem

  • G. Michael Deeb

  • Susheel Kodali

  • Isaac George

  • Mathew Williams

  • Steven Yakubov

  • A. Pieter Kappetein

  • Patrick Serruys

Medical Centers

  • The Heart Centre, University of Copenhagen, Copenhagen, Denmark

  • Rigshospitalet University hospital, Copenhagen, Denmark

  • University of Michigan Hospitals, Ann Arbor, Michigan, United States

  • Houston Methodist DeBakey Heart & Vascular Center, Houston, Texas, United States

  • Riverside Methodist Hospital, Columbus, Ohio, United States

  • NYU Langone Medical Center, New York, New York, United States

  • Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

  • New York Presbyterian Hospital-Columbia University Medical Center, New York, New York, United States

  • Imperial College, London, United Kingdom

  • Department of Cardiothoracic Surgery, Erasmus University Medical Center, Rotterdam, Netherlands

  • Thorax Center, Erasmus Medical Center, Rotterdam, Netherlands

  • Columbia, Hastings on Hudson, New York, United States

Locations

  • Denmark

  • United States

  • Netherlands

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Multi-vessel disease

  • Left main disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved